Injection delivery system developer ApiJect announced today that it completed a private investment round worth $111 million.
Royalty Pharma and Jefferies Financial Group led the investment round. Jefferies also acquired a revenue interest in addition to equity through the financing.
Get the full story at our sister site, Drug Delivery Business News.
ApiJect Systems announced today that Edward Kelley has joined as chief global health officer for the company.
Kelley will take on the role at Stamford, Connecticut-based ApiJect, which provides a platform for pharmaceutical companies to fill-finish their injectable medicines in prefilled delivery systems, as well as become a leader of its related organizations, ApiLabs and the ApiJect Global Initiative.
Get the full story at our sister site, Drug Delivery Business News.
Fareva and ApiJect Systems today announced a licensing agreement to fill-finish more than 500 million injectable drug doses per year.
Under the agreement, Fareva intends to invest more than $56.5 million to install three blow-fill-seal production lines with support from the Government of France through the France Relance industry initiative, as well as the Investments for the Future Program (PIA).
Get the full story at our sister site, Drug Delivery Business News.
Fareva and ApiJect Systems today announced a licensing agreement to fill-finish more than 500 million injectable drug doses per year.
Under the agreement, Fareva intends to invest more than $56.5 million to install three blow-fill-seal production lines with support from the Government of France through the France Relance industry initiative, as well as the Investments for the Future Program (PIA).
Get the full story at our sister site, Drug Delivery Business News.